Modafinilo Aurovitas

Modafinil, the active ingredient in Modafinilo Aurovitas, is a eugeroic (wakefulness‑promoting agent) presented as an oral tablet for oral use. It is indicated for the treatment of excessive daytime sleepiness associated with narcolepsy, obstructive sleep apnea, and shift work disorder.

GNH USA supplies Modafinilo Aurovitas as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to EU GMP standards and providing reliable distribution across multiple regions.

Modafinil is a central nervous system stimulant used to improve wakefulness in sleep‑related disorders.

Narcolepsy: reduces excessive daytime sleepiness and improves alertness in patients with narcolepsy. Obstructive sleep apnea (OSA): alleviates residual daytime sleepiness when used alongside standard OSA therapy. Shift work disorder: helps maintain alertness during scheduled work hours for individuals with shift‑work disorder.

Common Side Effects: - Headache - Nausea - Insomnia - Dry mouth

Serious or Rare Side Effects: - Severe rash or Stevens‑Johnson syndrome - Psychiatric disturbances such as hallucinations or depression - Cardiovascular events including hypertension or arrhythmia

Before initiating therapy, consider the following precautions: - Assess cardiovascular status: evaluate blood pressure and heart rhythm. - Review psychiatric history: avoid in patients with uncontrolled psychosis. - Consider hepatic function: dose may need adjustment in severe liver impairment. - Avoid concomitant use with potent CYP3A4 inhibitors: may increase plasma levels. - Store at ambient temperature below 25°C: keep in the original pack, protect from moisture.

Modafinil may interact with several medicines; careful assessment is required.

Major Interactions (Avoid): - CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): can markedly increase modafinil concentrations. - CYP3A4 inducers (e.g., rifampin, carbamazepine): can reduce efficacy by lowering drug levels.

Moderate Interactions (Monitor Closely): - Oral contraceptives: modafinil may reduce hormonal efficacy; consider alternative contraception. - Antidepressants (e.g., SSRIs, SNRIs): may increase risk of serotonin syndrome. - Antihypertensives: modafinil may diminish blood pressure control; monitor blood pressure regularly.